Table 5 Univariate overall survival and event-free survival analysis in 59 patients with STS.
From: The diagnostic and prognostic value of interleukin-6 in patients with soft tissue sarcomas
Variables | n | Overall survival | p value | Event-free survival | p value | ||
|---|---|---|---|---|---|---|---|
2-year | 5-year | 2-year | 5-year | ||||
Age | |||||||
>66 years | 32 | 75.9% | 67.4% | 0.5 | 63.1% | 34.5% | 0.53 |
<66 years | 27 | 88.3% | 57.7% | 68.9% | 54.8% | ||
Gender | |||||||
Male | 32 | 85.5% | 75% | 0.33 | 65.1% | 44.3% | 0.95 |
Female | 27 | 77.6% | 34.1% | 66.5% | NA | ||
Tumor depth | |||||||
Superficial | 10 | 80% | 80% | 0.54 | 70% | 70% | 0.36 |
Deep | 49 | 82% | 51.9% | 64.7% | 36% | ||
Tumor size | |||||||
>10 cm | 26 | 82.8% | NA | 0.82 | 69.4% | NA | 0.31 |
<10 cm | 33 | 81% | 61.5% | 62.5% | 39.7% | ||
Tumor grade | |||||||
G1 | 16 | 100% | 100% | 0.0006 | 100% | 80% | 0.008 |
G2 | 20 | 90% | 77.50% | 62.3% | 24.9% | ||
G3 | 23 | 64.30% | 34.60% | 47.1% | 33.5% | ||
IL-6 | |||||||
>26.7 pg/ml | 14 | 35.70% | NA | <0.0001 | 19% | NA | <0.0001 |
<26.7 pg/ml | 45 | 97.70% | 76.10% | 80.3% | 52.7% | ||
